<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Neuroscience</journal-id>
      <journal-title>Neuroscience</journal-title>
      <issn pub-type="ppub">0306-4522</issn>
      <issn pub-type="epub">1873-7544</issn>
      <publisher>
        <publisher-name>Elsevier Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2771270</article-id>
      <article-id pub-id-type="pmid">19409230</article-id>
      <article-id pub-id-type="publisher-id">NSC10922</article-id>
      <article-id pub-id-type="doi">10.1016/j.neuroscience.2009.01.045</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neurological Disorder</subject>
          <subj-group>
            <subject>Review</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Magnetic resonance imaging of Huntington's disease: preparing for clinical trials</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Klöppel</surname>
            <given-names>S.</given-names>
          </name>
          <email>stefan.kloeppel@uniklinik-freiburg.de</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Henley</surname>
            <given-names>S.M.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hobbs</surname>
            <given-names>N.Z.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wolf</surname>
            <given-names>R.C.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kassubek</surname>
            <given-names>J.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tabrizi</surname>
            <given-names>S.J.</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">e</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Frackowiak</surname>
            <given-names>R.S.J.</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">f</xref>
          <xref rid="aff7" ref-type="aff">g</xref>
          <xref rid="aff8" ref-type="aff">h</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>a</sup>Department of Psychiatry and Psychotherapy, Freiburg Brain Imaging, University Clinic Freiburg, Hauptstrasse, 79108 Freiburg, Germany</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>b</sup>Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>c</sup>Department of Psychiatry and Psychotherapy III, University of Ulm, Leimgrubenweg, 89075 Ulm, Germany</addr-line>
      </aff>
      <aff id="aff4">
        <addr-line><sup>d</sup>Department of Neurology, University of Ulm, Oberer Eselsberg, 89081 Ulm, Germany</addr-line>
      </aff>
      <aff id="aff5">
        <addr-line><sup>e</sup>Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK</addr-line>
      </aff>
      <aff id="aff6">
        <addr-line><sup>f</sup>Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK</addr-line>
      </aff>
      <aff id="aff7">
        <addr-line><sup>g</sup>Département d'études cognitives, Ecole Normale Supérieure, 29 rue d'Ulm, Paris 75005, France</addr-line>
      </aff>
      <aff id="aff8">
        <addr-line><sup>h</sup>Laboratory of Neuroimaging, IRCCS Santa Lucia, Via Ardeatina, Roma 00179, Italy</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Tel: +49-761-270-5234; fax: +49-761-270-5416 <email>stefan.kloeppel@uniklinik-freiburg.de</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>24</day>
        <month>11</month>
        <year>2009</year>
      </pub-date>
      <volume>164</volume>
      <issue>1</issue>
      <fpage>205</fpage>
      <lpage>219</lpage>
      <history>
        <date date-type="accepted">
          <day>23</day>
          <month>1</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2009 Elsevier Ltd.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>IBRO</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>The known genetic mutation causing Huntington's disease (HD) makes this disease an important model to study links between gene and brain function. An autosomal dominant family history and the availability of a sensitive and specific genetic test allow pre-clinical diagnosis many years before the onset of any typical clinical signs. This review summarizes recent magnetic resonance imaging (MRI)–based findings in HD with a focus on the requirements if imaging is to be used in treatment trials. Despite its monogenetic cause, HD presents with a range of clinical manifestations, not explained by variation in the number of CAG repeats in the affected population. Neuroimaging studies have revealed a complex pattern of structural and functional changes affecting widespread cortical and subcortical regions far beyond the confines of the striatal degeneration that characterizes this disorder. Besides striatal dysfunction, functional imaging studies have reported a variable pattern of increased and decreased activation in cortical regions in both pre-clinical and clinically manifest HD-gene mutation carriers. Beyond regional brain activation changes, evidence from functional and diffusion-weighted MRI further suggests disrupted connectivity between corticocortical and corticostriatal areas. However, substantial inconsistencies with respect to structural and functional changes have been reported in a number of studies. Possible explanations include methodological factors and differences in study samples. There may also be biological explanations but these are poorly characterized and understood at present. Additional insights into this phenotypic variability derived from study of mouse models are presented to explore this phenomenon.</p>
      </abstract>
      <kwd-group>
        <title>Key words</title>
        <kwd>Huntington's disease</kwd>
        <kwd>imaging</kwd>
        <kwd>basal ganglia</kwd>
        <kwd>subject stratification</kwd>
      </kwd-group>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>AD, Alzheimer's disease</kwd>
        <kwd>BOLD, blood-oxygenation level dependent</kwd>
        <kwd>BSI, brain boundary shift integral</kwd>
        <kwd>CSF, cerebrospinal fluid</kwd>
        <kwd>DWI, diffusion-weighted imaging</kwd>
        <kwd>FA, fractional anisotropy</kwd>
        <kwd>fMRI, functional magnetic resonance imaging</kwd>
        <kwd>FWHM, full-width at half-maximum</kwd>
        <kwd>GM, grey matter</kwd>
        <kwd>HD, Huntington's disease</kwd>
        <kwd>ICA, independent component analysis</kwd>
        <kwd>MRI, magnetic resonance imaging</kwd>
        <kwd>PD, Parkinson's disease</kwd>
        <kwd>PSC, presymptomatic gene carriers</kwd>
        <kwd>ROI, region of interest</kwd>
        <kwd>TCN, temporally coherent networks</kwd>
        <kwd>TIV, total intracranial volume</kwd>
        <kwd>VBM, voxel-based morphometry</kwd>
        <kwd>WM, white matter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder with an average age of onset around 40 years and an incidence of ∼4–10 per 100,000 in the United States and Western European countries. It is caused by a CAG repeat expansion in the gene encoding the protein huntingtin. The availability of a sensitive and specific genetic test allows pre-clinical diagnosis, many years before the onset of unequivocal motor signs (<xref rid="bib118" ref-type="bibr">Walker, 2007</xref>).</p>
    <p>Within the present overview, we plan to update and extend recent review articles on imaging in HD (<xref rid="bib41 bib71 bib2 bib16" ref-type="bibr">Henley et al., 2005; Montoya et al., 2006; Aylward, 2007; Bohanna et al., 2008</xref>). We will focus on the use of imaging for clinical therapeutic trials and will consider factors that need to be taken into account when designing them. In a disease like HD, there is a need to follow the effects of neuro-degeneration in individuals over time to evaluate degeneration-modifying treatments. Optimally, monitoring should occur in both the pre-clinical and clinically manifest stages of the disease. Currently, it is difficult to monitor the progression of neuro-degeneration in asymptomatic individuals using clinical or neuropsychological testing. Ideally, imaging would be used to stratify subjects by degree of caudate atrophy, well before the onset of unequivocal clinical signs. Such stratification would potentially make it possible to stage subjects into more homogeneous populations and to assess the effects of treatments on different stages in the evolution of this neuro-degenerative disorder.</p>
    <p>We will focus mainly on T1-weighted structural imaging methods since treatment trials are likely to include multiple clinical centers where technical requirements for diffusion weighted imaging (DWI) or functional magnetic resonance imaging (fMRI) studies are often not readily available and potentially more difficult to standardize. There are however first encouraging data from DWI (<xref rid="bib56 bib117" ref-type="bibr">Landman et al., 2007; Wakana et al., 2007</xref>) and fMRI studies (<xref rid="bib17" ref-type="bibr">Bosnell et al., 2008</xref>) preparing for multi-center and multimodality strategies and applications in the future.</p>
    <p>We start by briefly outlining structural imaging methods, including some caveats in their application. In the second section, we highlight current evidence for structural imaging abnormalities in HD, associations between atrophy visualized <italic>in vivo</italic> and clinical performance, and discuss imaging evidence for the stratification of HD subjects based on, e.g. the number of CAG repeats, clinical phenotype, or pattern of cognitive impairment. We consider this critical for the optimal design of clinical trials, as clinically defined characteristics may be associated with differential rates and distribution of degeneration. The third and fourth section reviews fMRI and DWI data with a focus on their usefulness for the characterization of individual subjects before entering treatment trials. The fifth section summarizes data from imaging studies in HD mouse models and illustrates how such data aid in the stratification of subjects and in the interpretation of imaging findings.</p>
    <p>Beyond issues related to imaging-based criteria for subject inclusion in trials, the next step will be to find sensitive methods to detect possible effects of proposed treatments. The concluding section therefore provides an update on the ongoing discussion about imaging-derived measures as biomarkers of disease progression.</p>
    <p>This selective review will restrict itself to magnetic resonance imaging (MRI). Imaging of cerebral blood flow and glucose metabolism has been the focus of another recent review (<xref rid="bib64" ref-type="bibr">Ma and Eidelberg, 2007</xref>).</p>
    <sec id="sec1">
      <title>Structural imaging methods</title>
      <p>Structural MRI analyses in HD have yielded inconsistent findings (see 2nd section). Discrepancies are likely to be due to methodological differences in the analysis techniques applied, as well as true heterogeneity in the cohorts studied. In this section we summarize some of the image analysis techniques currently used to investigate neurodegeneration in HD.</p>
      <p>Structural MRI investigations typically fall into two categories: (1) hypothesis-driven region of interest (ROI) studies on pathologically-affected structures, and (2) more exploratory unbiased whole-brain analyses, requiring no a priori assumptions.</p>
      <sec id="sec1.1">
        <title>ROI analyses</title>
        <p>The current gold-standard measurement technique for ROI volumetry is manual segmentation. This involves an expert rater tracing around the outline of the structure on every “slice” of the MR image. Manual segmentation has been used extensively to investigate atrophy in the caudate, putamen, frontal lobe, and globus pallidus (<xref rid="bib40 bib7 bib3 bib6 bib90 bib92 bib28 bib79" ref-type="bibr">Harris et al., 1992; Aylward et al., 1997, 1998; Aylward et al., 2000; Rosas et al., 2001, 2003; Fennema-Notestine et al., 2004; Paulsen et al., 2006b</xref>). However, this approach is extremely time consuming, and results are subject to inter- and intra-rater variability.</p>
        <p>As an alternative to manual-outlining algorithms, several fully automated segmentation and anatomical labeling techniques have been developed (<xref rid="bib50" ref-type="bibr">Khan et al., 2008</xref>). These techniques are likely to be used more frequently in future studies if they are shown to be reliable. Both manual- and automated-ROI-based analyses are limited by difficulties in accurately and reliably outlining small structures, especially if the structure is complex and contains poorly defined boundaries.</p>
      </sec>
      <sec id="sec1.2">
        <title>Whole-brain analyses</title>
        <p>The most elementary whole-brain analysis is visual assessment of the MR images by a radiologist. However, quantification via visual rating scales is crude and subject to inter- and intra-rater variation.</p>
        <p>The brain boundary shift (BSI) integral is a semi-automated technique for measuring whole-brain volume change from serial MRI (<xref rid="bib33" ref-type="bibr">Freeborough and Fox, 1997</xref>), and can be used to capture the full extent of diffuse cerebral volume loss in HD (<xref rid="bib42" ref-type="bibr">Henley et al., 2006</xref>). The volume of atrophy is measured directly from the difference in brain boundaries of registered scan pairs, thereby, reducing the impact of segmenter variability on results since the quantification does not rely on manual segmentation per se. One limitation of the BSI is its inability to localize change to specific tissues. In addition, there is a possibility that degeneration in one structure might be accompanied by an enlargement in another which may not result in changes at the brain boundary.</p>
        <p>Voxel-based morphometry (VBM) (<xref rid="bib1" ref-type="bibr">Ashburner and Friston, 2000</xref>) and cortical thickness analyses (<xref rid="bib31 bib59" ref-type="bibr">Fischl and Dale, 2000; Lerch et al., 2008a</xref>) are unbiased whole-brain-based methods used to study the pattern of neurodegeneration and neuro-anatomical correlates of HD. Although these methods are automated, there are numerous differences between research groups in the software used, the processing steps and statistical models applied, and the correction of the resulting statistical parametric maps, all of which may affect overall results. A principled approach is therefore mandatory.</p>
        <p>In brief, VBM requires a series of automated image pre-processing steps, including segmenting images into grey matter (GM), white matter (WM) and cerebrospinal fluid (CSF) compartments, spatially aligning (normalizing) these compartments into standard stereotactic space and applying appropriate smoothing for subsequent analysis at group level. A number of different analytical path specifications have been used and reported: some studies optimize the normalization but not segmentation, some use a study-specific template for normalization and these may be whole brain templates or templates designed for the tissue classes under study. Some researchers introduce other new steps into the analytic path with varying degrees of a priori justification (compare, e.g. <xref rid="bib111 bib82 bib24" ref-type="bibr">Thieben et al., 2002; Peinemann et al., 2005; Douaud et al., 2006</xref>).</p>
        <p>Within the few published cortical thickness analyses in HD, there is variation in both the software and methodology applied. Rosas et al. (e.g. <xref rid="bib94" ref-type="bibr">Rosas et al., 2008</xref>) use the surface-based software package FreeSurfer (<xref rid="bib31" ref-type="bibr">Fischl and Dale, 2000</xref>), which automatically extracts the inner and outer cortical surfaces using deformable models, and calculates cortical thickness as the shortest distance between the pial and WM surfaces (<xref rid="bib31" ref-type="bibr">Fischl and Dale, 2000</xref>). By contrast, cortical thickness measurements in the YAC128 mouse-model study (see further below) use Laplace's equation to create streamlines between the inside and outside cortical surfaces, with the length of streamline giving the measurement of thickness (<xref rid="bib59" ref-type="bibr">Lerch et al., 2008a</xref>). <xref rid="bib75" ref-type="bibr">Nopoulos et al. (2007)</xref> used the BRAINS2 family of software programs (<xref rid="bib65" ref-type="bibr">Magnotta et al., 2002</xref>) to extract a model representing the parametric center of the GM tissue class, which approximates the spatial center of the cortex. Here, cortical depth is measured as the minimum distance between the 100% GM surface and the center of the cortex (i.e. 50%/50% GM/WM surface). These methodological differences are likely to have some effect on results and should be considered when comparing studies of cortical thickness.</p>
        <p>There is a large amount of inconsistency in the specification of the covariates included in statistical models for analysis (<xref rid="bib76" ref-type="bibr">O'Brien et al., 2006</xref>). VBM studies often, but not always, include age, gender, and total intracranial volume (TIV) as nuisance factors, since they can affect brain volume independently of disease. VBM studies also tend to adjust for total GM volume. This approach allows for investigation of region-specific patterns of atrophy and relative atrophy or preservation of tissue (<xref rid="bib74" ref-type="bibr">Muhlau et al., 2007</xref>); however it is important that GM volume is not used as a substitute for head size, particularly in studies of neurodegeneration, as total as well as regional GM volume may vary with disease severity and duration. Cortical thickness. Cortical thickness analyses tend to correct for age and gender but not TIV. There appears to be no relationship between brain size and cortical thickness in mice (<xref rid="bib59" ref-type="bibr">Lerch et al., 2008a</xref>) but recent work indicates that the relative dimensions of sulcal depth with respect to cortical thickness change with head size in humans (<xref rid="bib45" ref-type="bibr">Im et al., 2008</xref>).</p>
        <p>Some smoothing is generally required to compensate for small variation in individual anatomy during inter-subject registration, and to ensure that the data are normally distributed (statistically stationary). The amount of smoothing sensitizes analyses to a particular spatial scale of effect (<xref rid="bib88" ref-type="bibr">Ridgway et al., 2008</xref>) which will affect interpretation of results; the detection of change in a structure is more sensitive if the smoothing kernel approximates the size of the structure. For VBM analyses, segments are smoothed through convolution with a volumetric gaussian kernel. Kernel sizes in the HD literature range from full-width at half-maximum (FWHM) 4 mm (<xref rid="bib12" ref-type="bibr">Barrios et al., 2007</xref>) to 12 mm (<xref rid="bib52" ref-type="bibr">Kipps et al., 2005</xref>). However, the majority of studies do not justify their choice of smoothing kernel, for example, by attempting to match the spatial extent to that of the degenerative change expected (see <xref rid="bib48" ref-type="bibr">Kassubek et al., 2004b</xref> for an example of selecting the smoothing kernel based on visual inspection of structural changes). In cortical thickness analyses, smoothing is typically carried out across the cortical surface to follow the topology of the cortex (<xref rid="bib93 bib91 bib94 bib59" ref-type="bibr">Rosas et al., 2002, 2005, 2008; Lerch et al., 2008a</xref>). The amount of smoothing varies greatly in the few cortical papers published, for example <xref rid="bib91" ref-type="bibr">Rosas et al. (2005)</xref> used a 2D gaussian kernel of FWHM 29 mm but a 3D kernel of FWHM 16 mm in earlier work. <xref rid="fig1" ref-type="fig">Fig. 1</xref> shows the effects of varying a surface-based gaussian smoothing kernel from FWHM 10–30 mm on the same dataset. As the kernel size increases, the area of significant differences tends to increase. Therefore, differences between studies using different smoothing kernel types may not reflect true disease-related differences in the cohorts studied. For example, <xref rid="bib59" ref-type="bibr">Lerch et al. (2008a)</xref> found an increase in cortical thickness of the sensorimotor cortex in the YAC128 mouse HD model relative to wild-type mice at a stage representing very early stage HD/presymptomatic gene carriers (PSC). This finding agrees with some results from human PSC (<xref rid="bib79" ref-type="bibr">Paulsen et al., 2006b</xref>), but contradicts others; <xref rid="bib91" ref-type="bibr">Rosas et al. (2005)</xref> found regionally-selective thinning and no areas of thickening in their PSC cohort.</p>
        <p>In summary, this section has illustrated a number of methodological issues which are likely to influence imaging findings. However, it is difficult to predict how each issue will affect the overall result. The effects of smoothing-kernel size have been explored systematically (<xref rid="bib46" ref-type="bibr">Jones et al., 2005</xref>) but are likely to be dependent on the specific study. In contrast, the effect of changing regressors in the statistical design or using different means for spatial normalization is very difficult to predict. Such methodological issues need to be considered when trying to interpret the HD literature and to generalize results. Ideally, as has been suggested recently (<xref rid="bib75" ref-type="bibr">Nopoulos et al., 2007</xref>), researchers need to consolidate methods in order to produce findings that are replicable, robust, and truly representative of HD. Recently published sets of guidelines (<xref rid="bib88" ref-type="bibr">Ridgway et al., 2008</xref>) could prove helpful in that respect. Such general guidelines are preferable to very specific ones (e.g. a specific smoothing kernel or a specific set of covariates) as their choice will depend on the exact research question and dataset being investigated.</p>
      </sec>
    </sec>
    <sec id="sec2">
      <title>Structural correlates of clinical features and subject stratification</title>
      <p>In this section, we summarize recent structural MRI work in HD, as well as how these <italic>in vivo</italic> findings relate to the clinical features observed in disease. We also highlight evidence that stratification based on e.g. number of CAG repeats or clinical phenotype, yields distinct patterns of atrophy. Tables providing an excellent overview of previously published studies are provided in another review (<xref rid="bib16" ref-type="bibr">Bohanna et al., 2008</xref>).</p>
      <sec id="sec2.1">
        <title>Structural MRI in HD</title>
        <p>The most striking pathological changes in HD occur in the striatum (<xref rid="bib37 bib36" ref-type="bibr">Halliday et al., 1998; Gutekunst et al., 2002</xref>) and there is a wealth of evidence that striatal atrophy can be detected using MRI up to 23 years prior to predicted motor onset and that striatal volume is negatively correlated with motor and cognitive function and CAG repeat length (<xref rid="bib40 bib38 bib39 bib4 bib5 bib8 bib90 bib48 bib79" ref-type="bibr">Harris et al., 1992, 1996, 1999; Aylward et al., 1994, 1996, 2004; Rosas et al., 2001; Kassubek et al., 2004b; Paulsen et al., 2006b</xref>; <xref rid="fig2" ref-type="fig">Fig. 2</xref>).</p>
        <p>The contribution of cortical regions to the pathophysiology of HD has been of increasing interest, since huntingtin-protein aggregates have been found to concentrate in cortical neurons to an even greater extent than in the striatum (<xref rid="bib30 bib101 bib35" ref-type="bibr">Ferrante et al., 1997; Sapp et al., 1997; Gutekunst et al., 1999</xref>). Extra-striatal atrophy has been reported in early HD including WM loss in the absence of total brain volume or GM loss (<xref rid="bib3 bib14" ref-type="bibr">Aylward et al., 1998; Beglinger et al., 2005</xref>). Others have reported reduced total brain volume or GM loss (<xref rid="bib92 bib28 bib47 bib48" ref-type="bibr">Rosas et al., 2003; Fennema-Notestine et al., 2004; Kassubek et al., 2004a,b</xref>).</p>
        <p>Reduced cortical thickness has been found in early to moderate HD, with a suggestion that the sensorimotor areas are most severely affected and that atrophy progresses from posterior to anterior regions with longer disease duration (<xref rid="bib93 bib94" ref-type="bibr">Rosas et al., 2002, 2008</xref>). Of studies taking a whole-brain rather than an ROI approach, most find evidence of bilateral caudate and putaminal atrophy in both early disease and in PSC (<xref rid="bib111 bib82" ref-type="bibr">Thieben et al., 2002; Peinemann et al., 2005</xref>). In contrast there is less consensus about extra-striatal atrophy; for example insular atrophy has been shown in PSC (<xref rid="bib111" ref-type="bibr">Thieben et al., 2002</xref>), but not in a study in early HD (<xref rid="bib48" ref-type="bibr">Kassubek et al., 2004b</xref>). There are similarly variable results on the involvement of the thalamus, amygdala, hypothalamus, and frontal areas (<xref rid="bib48 bib49 bib82 bib24 bib74" ref-type="bibr">Kassubek et al., 2004b, 2005; Peinemann et al., 2005; Douaud et al., 2006; Muhlau et al., 2007</xref>). This could be an effect of relatively small group sizes, different clinical stages or the choice of statistical thresholds. It should also be kept in mind that increasing levels of degeneration can result in problems with image registration in areas not themselves affected by disease (e.g. an inward shift of the insular cortex with shrinking striatal volume).</p>
        <p>Abnormal brain volume has also been found in PSC. A recent study found evidence of reduced WM but normal GM volume in PSC approximately 11 years from predicted clinical onset (<xref rid="bib79" ref-type="bibr">Paulsen et al., 2006b</xref>). In contrast, PSC estimated at 23 years from onset had more grey and less WM than normal, in the absence of any increase in ventricular size or CSF volume, which led the authors to postulate that their result may represent a developmental abnormality rather than a very early neurodegenerative process (<xref rid="bib79" ref-type="bibr">Paulsen et al., 2006b</xref>). Total brain volume was not significantly reduced although further work on the same cohort demonstrated morphological GM abnormalities, including increased gyral surface area, thicker gyri, and thinner sulci (<xref rid="bib75" ref-type="bibr">Nopoulos et al., 2007</xref>). Decreased WM has been reported to correlate with years to onset in PSC, while the same study showed a non-significant reduction of GM (<xref rid="bib21" ref-type="bibr">Ciarmiello et al., 2006</xref>). However, GM thinning in regions across the cortex has also been reported in this population (<xref rid="bib91" ref-type="bibr">Rosas et al., 2005</xref>).</p>
        <p>In summary, structural MRI studies in early HD tend to support the postmortem findings (<xref rid="bib116 bib36" ref-type="bibr">Vonsattel and DiFiglia, 1998; Gutekunst et al., 2002</xref>) of widespread generalized atrophy throughout the cortex, with disproportionate volume loss in the striatum. Where both GM and WM are measured, there is a suggestion that WM loss is relatively greater or seen earlier in the course of the degeneration (see section on DWI). PSC have clear striatal atrophy and there is evidence of WM loss but the involvement of cortical GM is less clear. There is considerable variation between studies both with regard to the extent of extra-striatal atrophy and the point in the disease process at which loss in different regions starts to become significant. In many cases these differences may be due to methodological differences or lack of statistical power caused by the small or heterogeneous groups selected for study. Alternatively, they may reflect true heterogeneity in the populations sampled. Although it is clear that widespread structural loss occurs early in the disease, more work is needed to define the pattern, time course, severity, significance, and evolution of these changes more clearly, particularly in the early PSC phase.</p>
        <p>The majority of longitudinal structural MRI studies in HD have focused on the striatum and it is now well established that striatal atrophy rates are increased prior to onset of motor symptoms and that they may not be linearly progressive, at least in the pre-clinical stage. Atrophy rate is also correlated with CAG repeat length (<xref rid="bib7 bib6 bib8 bib2" ref-type="bibr">Aylward et al., 1997, 2000, 2004; Aylward, 2007</xref>). Other studies focusing on the whole brain have reported a decrease in WM volume in PSC over periods as short as 16 months (<xref rid="bib21" ref-type="bibr">Ciarmiello et al., 2006</xref>), but others have reported atrophy of subcortical GM but no WM changes in PSC subjects over a period of 2 years (<xref rid="bib52" ref-type="bibr">Kipps et al., 2005</xref>). In clinically manifest HD, there have been reports of no change over 18 months (<xref rid="bib21" ref-type="bibr">Ciarmiello et al., 2006</xref>), increased whole-brain atrophy rates measured over 6 months (<xref rid="bib42" ref-type="bibr">Henley et al., 2006</xref>), and a decrease in insula, cerebellum and some regional cortical volumes over a 1-year period (<xref rid="bib96" ref-type="bibr">Ruocco et al., 2008</xref>). The specificity of the latter results may need clarification as subjects were aged from 4 to 73 years, but results were not adjusted for either age or head-size (<xref rid="bib96" ref-type="bibr">Ruocco et al., 2008</xref>).</p>
      </sec>
      <sec id="sec2.2">
        <title>Neural correlates of clinical performance in HD</title>
        <p>A number of imaging studies have confirmed the existence of a relationship between striatal volumes and cognitive deficits (<xref rid="bib11 bib109 bib18 bib38" ref-type="bibr">Bamford et al., 1989; Starkstein et al., 1992; Brandt et al., 1995; Harris et al., 1996</xref>). Measures of frontal lobe size correlate with memory and planning performance (<xref rid="bib11 bib10 bib9" ref-type="bibr">Bamford et al., 1989, 1995; Backman et al., 1997</xref>) and regions including the thalamus (<xref rid="bib49" ref-type="bibr">Kassubek et al., 2005</xref>), insula (<xref rid="bib82" ref-type="bibr">Peinemann et al., 2005</xref>), WM (<xref rid="bib14 bib95" ref-type="bibr">Beglinger et al., 2005; Rosas et al., 2006</xref>), and widespread cortical regions (<xref rid="bib91 bib94" ref-type="bibr">Rosas et al., 2005, 2008</xref>) are associated with cognitive performance in both PSC and early clinically manifest HD. Most of these studies have focused on a few tests in a specific domain (executive function) although recently it has also been shown that striatal and frontal regions are associated with performance on emotion recognition (<xref rid="bib44 bib53 bib43" ref-type="bibr">Hennenlotter et al., 2004; Kipps et al., 2007; Henley et al., 2008</xref>).</p>
      </sec>
      <sec id="sec2.3">
        <title>Stratification of subjects for clinical trials</title>
        <p>A problem in HD research is the heterogeneity of subject groups, making it hard to detect small differences in variables of interest or to track change over time. One solution is to stratify subjects based on clinical characteristics, and it has been demonstrated that such stratified groups do show different patterns of atrophy. When stratified by CAG repeat length, motor or cognitive score, subjects with longer repeat lengths (or worse scores) show more extensive atrophy, that also affects extra-striatal regions, than those with shorter repeat lengths (or better motor scores) (<xref rid="bib48" ref-type="bibr">Kassubek et al., 2004b</xref>), when compared with controls. PSC subjects, when stratified by estimated time to clinical onset, also demonstrate differences in the amount of striatal, grey and WM atrophy that are time dependent (<xref rid="bib78" ref-type="bibr">Paulsen et al., 2006a</xref>). More recently, there has been a suggestion that patients showing more bradykinetic features of HD show a different pattern of cortical thinning to those without these features (<xref rid="bib94" ref-type="bibr">Rosas et al., 2008</xref>). However, in most analyses of this type small subgroups were compared with controls, rather than directly with each other. Therefore, more work is needed to validate MRI differences and to determine whether they can be used to stratify pre-clinical and symptomatic subjects so that more homogeneous cohorts can be entered into clinical trials.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Functional MRI in HD</title>
      <p>Within the past 5 years, fMRI has been increasingly used to study basic sensory, emotional and cognitive processes in HD. In this section we seek to update the reader on new developments in fMRI research since the review recently provided by <xref rid="bib16" ref-type="bibr">Bohanna et al.(2008)</xref> and address three main questions that arise from published fMRI findings in clinical HD and PSC.</p>
      <sec id="sec3.1">
        <title>Does evidence from fMRI suggest a distinct pattern of neural dysfunction during cognitive processing in HD?</title>
        <p>Published fMRI studies (see <xref rid="bib16" ref-type="bibr">Bohanna et al., 2008</xref> for tables providing an overview of the main findings) have shown that abnormal activation patterns including hyper- and hypo-activation in HD patients and PSC are not restricted to the striatum. The stage of the disease as well as the clinical phenotype might contribute to data heterogeneity, and differential patterns of neural dysfunction during different stages of the illness still have to be determined in larger patient cohorts. Taking these clinical limitations into account, the extant fMRI data in clinical HD suggest a complex pattern of neural dysfunction during cognitive processing, including a widespread set of subcortical and cortical regions which have been found to show abnormal brain activation responses compared to healthy subjects. These findings, however, do not converge to define a single functional biomarker of HD, but rather suggest a dynamic pattern of neural dysfunction in clinical HD and PSC which possibly depend on task type, cognitive demand, task performance, or a combination of all three variables.</p>
        <p>For instance, abnormal activation of the anterior cingulate cortex in clinical HD has been shown during the Simon response conflict task (<xref rid="bib34" ref-type="bibr">Georgiou-Karistianis et al., 2007</xref>), but not during processing by working memory (<xref rid="bib123" ref-type="bibr">Wolf et al., 2008c</xref>) or during implicit motor learning (<xref rid="bib51" ref-type="bibr">Kim et al., 2004</xref>). These results suggest that the detection threshold for aberrant neural responses in the cingulate cortex could be task-dependent. Furthermore, although the majority of fMRI studies have so far demonstrated reduced task performance during cognitive processing in clinical HD (<xref rid="bib51 bib34 bib123" ref-type="bibr">Kim et al., 2004; Georgiou-Karistianis et al., 2007; Wolf et al., 2008c</xref>), the relationship between task performance and brain dysfunction has to be determined, since both decreased brain activation (<xref rid="bib123" ref-type="bibr">Wolf et al., 2008c</xref>) and increased functional connectivity (<xref rid="bib112" ref-type="bibr">Thiruvady et al., 2007</xref>) in clinical HD have been discussed against the background of impaired task accuracy. Several authors have discussed cortical hyperactivation shown by fMRI in terms of neural “compensation” (<xref rid="bib81 bib34 bib124 bib127" ref-type="bibr">Paulsen et al., 2004; Georgiou-Karistianis et al., 2007; Wolf et al., 2007; Zimbelman et al., 2007</xref>), although the compensatory processes related to functional abnormalities remains to be characterized in terms of a task-related mechanism. Indeed, increased brain activation in the presence of task-stimulation does not necessarily have to mirror task-specific processes, and thus other explanations appear plausible, e.g. the possibility of abnormally increased activation that interferes with brain activation typically elicited by a given task. For instance, a positive correlation between the UHDRS motor score and activation of right dorsal and left ventral premotor regions has been reported in clinically affected patients with HD while performing a response conflict task (<xref rid="bib34" ref-type="bibr">Georgiou-Karistianis et al., 2007</xref>). The authors interpreted this relationship as related to characteristics of the disease, and suggested that patients with more severe motor symptoms could exhibit greater baseline motor region activity in order to inhibit involuntary movements, while the alternative interpretation of a relationship between premotor activation and increasing task difficulty needs further validation.</p>
        <p>Moreover, the question is open whether brain activation abnormalities during cognitive performance as shown in HD are qualitatively different from the pattern of neural dysfunction observed in other basal ganglia disorders, e.g. Parkinson's disease (PD) (<xref rid="bib70 bib61" ref-type="bibr">Monchi et al., 2000; Lewis et al., 2003</xref>). For instance, reduced activation of the prefrontal cortex and the putamen during working memory performance has been reported in both patients with PD (<xref rid="bib61" ref-type="bibr">Lewis et al., 2003</xref>) and HD (<xref rid="bib123" ref-type="bibr">Wolf et al., 2008c</xref>). Furthermore, somewhat similar to fMRI findings in HD, patterns of both increased and decreased brain activation have been previously reported in PD patients during executive processing (<xref rid="bib68" ref-type="bibr">Monchi et al., 2007</xref>). While the notion of a differential engagement of the caudate nucleus during distinct processing phases of a cognitive task (<xref rid="bib69 bib68" ref-type="bibr">Monchi et al., 2006, 2007</xref>) could partially explain divergent findings of increased and reduced brain activation in HD and PSC, this hypothesis clearly needs to be explicitly tested in HD patients and PSC.</p>
        <p>Eventually, it is also unclear if increased brain activation in HD patients and PSC could also reflect increased cortical “noise” and thus a loss of regional specialization (<xref rid="bib84" ref-type="bibr">Rajah and D'Esposito, 2005</xref>), e.g. due to a generalized dopaminergic deficit, rather than reflecting circumscribed deficits due to the disease or due to task-specific factors. Furthermore, the impact of GM volume changes and abnormal neurovascular coupling on neural activation and blood-oxygenation level dependent (BOLD) responses is not well-known yet, and could additionally lead to aberrant BOLD fluctuations associated with neurodegeneration and cerebrovascular dysregulation (<xref rid="bib23 bib22" ref-type="bibr">Deckel et al., 1998; Deckel, 2001</xref>).</p>
      </sec>
      <sec id="sec3.2">
        <title>Can functional connectivity analyses provide further insights into early pathophysiological processes in PSC and into disease-related brain dysfunction during the symptomatic period?</title>
        <p>Given the association between striatal abnormalities and cognitive performance in PSC (<xref rid="bib9 bib108" ref-type="bibr">Backman et al., 1997; Solomon et al., 2007</xref>), as well as anatomical evidence for topographically organized reciprocal connections between the striatum and neocortex (<xref rid="bib67" ref-type="bibr">Middleton and Strick, 2000</xref>), it has been suggested that dysfunction of corticostriatal circuits may characterize pre-clinical stages of HD (<xref rid="bib86 bib27" ref-type="bibr">Reading et al., 2004; Feigin et al., 2006</xref>) before the onset of overt brain atrophy and motor, psychiatric or cognitive disturbances.</p>
        <p>It is unclear at present if regionally abnormal brain activation during the presymptomatic period reflects aberrant corticostriatal pathways related to progressive subcortical atrophy, or if a primarily cortical deficit independent of the neurodegenerative process in the striatum could additionally account for findings of primarily cortical dysfunction in PSC (<xref rid="bib87 bib124" ref-type="bibr">Reading et al., 2005; Wolf et al., 2007</xref>). Although it is neuroanatomically plausible that cortical regions showing abnormal activation in PSC could reflect an early disruption of corticostriatal networks, e.g. as a consequence of impaired corticostriatal connectivity, recent evidence suggests that aberrant connectivity of functionally related networks extends beyond corticostriatal decoupling. For instance, a lower expression of functional networks involving dissociable dorsolateral prefrontal circuits was found in PSC during working memory processing despite absent differences in task performance compared to healthy controls (<xref rid="bib121" ref-type="bibr">Wolf et al., 2008a</xref>). By means of a model-free multivariate analysis technique (independent component analyses; ICA), two distinct temporally coherent networks (TCNs) (<xref rid="bib19" ref-type="bibr">Calhoun et al., 2008a</xref>) were identified that were positively correlated with the delay period of a verbal working memory paradigm. These TCNs comprised cortical and subcortical regions specified by a distinct spatiotemporal pattern comprising frontostriatal and fronto-parietal areas (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). In PSC, decreased functional connectivity was found in left lateral prefrontal and bilateral striatal areas, as well as in left fronto-parietal regions compared to healthy controls. Interestingly, contributions of the lateral prefrontal cortex were not confined to frontostriatal pathways, but were also detected in left lateralized fronto-parietal networks with sparing of the striatum, suggesting additional cortical decoupling without involvement of subcortical structures (<xref rid="bib121" ref-type="bibr">Wolf et al., 2008a</xref>). It is yet an open question however, whether impaired striatal transmission can also explain the latter findings since multimodal imaging data (e.g. PET and fMRI measures obtained in an identical PSC sample) are lacking at present.</p>
        <p>Regionally increased activation of the anterior cingulate cortex (<xref rid="bib34" ref-type="bibr">Georgiou-Karistianis et al., 2007</xref>), as well as disrupted functional connectivity between the anterior cingulate and lateral prefrontal cortex has been shown in clinically affected subjects. The latter finding was associated with slower reaction times and more frequent errors during a Simon task (<xref rid="bib112" ref-type="bibr">Thiruvady et al., 2007</xref>). These findings are suggestive of a functional decoupling between the anterior cingulate and the lateral prefrontal cortex in HD patients, which might partly account for the deterioration in performance. Increased cortical activation could mirror regional compensatory processes as a result of this impaired connectivity (<xref rid="bib112" ref-type="bibr">Thiruvady et al., 2007</xref>). In contrast to these findings, impaired brain activation in the absence of coincidental hyper-activation has been found during working memory processing at intermediate and high levels of cognitive processing (<xref rid="bib124" ref-type="bibr">Wolf et al., 2007</xref>). One possible explanation for these findings is related to load-dependent mechanisms of frontostriatal function, which have been repeatedly shown with fMRI in healthy subjects (<xref rid="bib98 bib99 bib125" ref-type="bibr">Rypma and D'Esposito, 1999; Rypma et al., 1999; Wolf and Walter, 2005</xref>). With low task demands, brain activation during cognitive processing may be similar in HD patients and controls, or may augment as a consequence of increased cognitive effort to optimize task performance. Given the possible load-dependency of neural dysfunction in clinical HD, parametric activation paradigms may be more suitable for assessment of gradual brain activation and related functional connectivity changes between cortical regions and the striatum (<xref rid="bib122" ref-type="bibr">Wolf et al., 2008b</xref>).</p>
      </sec>
      <sec id="sec3.3">
        <title>Are functional brain activation changes in clinical HD and PSC subjects sensitive and reliable biomarkers of neurodegeneration and disease progression?</title>
        <p>The role of fMRI in tracking disease progression needs further evaluation at present. For instance, volumetric data suggest a relative decrease of striatal GM in PSC (<xref rid="bib52" ref-type="bibr">Kipps et al., 2005</xref>) and cortical volume changes in HD patients over time (<xref rid="bib96" ref-type="bibr">Ruocco et al., 2008</xref>) however longitudinal fMRI data in both PSC and HD patients are lacking so far. Thus, it is unclear at present if functional or volumetric data are equally sensitive in the detection of early abnormalities in PSC and for tracking disease progression. Moreover, although inferences can be made using cross-sectional years to clinical onset data (<xref rid="bib81 bib124 bib127 bib100" ref-type="bibr">Paulsen et al., 2004; Wolf et al., 2007; Zimbelman et al., 2007; Saft et al., 2008</xref>), it is still not possible to determine the temporal dynamics of brain activation changes starting from the very early symptomatic period to overtly manifest HD. In designing longitudinal fMRI studies of HD, certain clinical and methodological issues should be taken into account. First, phenotypic variability in HD could represent a potential confound, which may reduce the power of fMRI designs using cognitive paradigms. Moreover, although a number of studies have shown cognitive deficits in PSC subjects (<xref rid="bib57 bib107 bib58" ref-type="bibr">Lawrence et al., 1996; Snowden et al., 2002; Lemiere et al., 2004</xref>), the variability in cognitive performance has also been emphasized (<xref rid="bib63" ref-type="bibr">Lundervold and Reinvang, 1995</xref>). Cognitive impairment does not evolve uniformly in PSC, either over time or with respect to specific cognitive domains (<xref rid="bib58" ref-type="bibr">Lemiere et al., 2004</xref>), again suggesting a neurobiological and phenotypic variability which has to be taken into account in future longitudinal studies. Studies of multiple cognitive domains (e.g. psychomotor speed, attention, memory and executive function) in populations using short, robust cognitive activation paradigms may offer a unique opportunity to validate a range of stimulation tasks. Those could be used in clinical HD exhibiting manifest cognitive impairment and PSC individuals with subtle cognitive deficits below the clinical threshold and associated neural abnormalities in one or more cognitive domains. Second, practice and learning effects or other strategic factors inherent in given cognitive tasks must be considered as they may be responsible for substantial inter- and intra-individual differences in cognitive capacity (<xref rid="bib98 bib97" ref-type="bibr">Rypma and D'Esposito, 1999; Rypma et al., 2002</xref>). Of note, inferring neural dysfunction in pre-HD so far has been derived from group activation maps, and there is no clear consensus at present how data from complex cognitive activation tasks should be treated at the individual level. Furthermore, methodological heterogeneity in analyzing fMRI data might limit the comparability between studies to a certain extent. While both ROI-driven approaches and whole-brain analyses have been employed, most studies relied on a priori models for the estimation of the hemodynamic response in the context of task-induced stimulation blocks or events. In this context, multivariate statistical analyses might yield more robust results than those obtained by a general linear model approach (<xref rid="bib20" ref-type="bibr">Calhoun et al., 2008b</xref>). However, these increasingly used analysis and modeling techniques for fMRI data clearly need further evaluation before being implemented in a clinical trial design.</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>Diffusion weighted imaging</title>
      <p>This method measures the diffusion of water molecules, which is influenced by the fiber architecture of the WM. It allows a voxel-by-voxel comparison of diffusion properties, mostly fractional anisotropy (FA) and mean diffusivity (<xref rid="bib13" ref-type="bibr">Beaulieu, 2002</xref>). It also permits the tracking of WM fiber connections between different regions of the brain (<xref rid="bib72" ref-type="bibr">Mori et al., 1999</xref>). A recent review (<xref rid="bib16" ref-type="bibr">Bohanna et al., 2008</xref>) provides an up-to-date overview of findings in HD. Most consistently reported findings include increases in FA in the putamen and globus pallidum.</p>
      <p>It is not straightforward to conclude a specific histological correlate of such FA changes. FA is a measure of the anisotropy of the diffusion and ranges from zero to 1. FA is highest (anisotropic diffusion) in the large fiber tracts such as the cortico-spinal tract but lower where fibers from different directions are crossing or within the GM. It effectively reflects the coherence of the WM. Studies on the histological basis of FA changes usually focused on wallerian degeneration following traumatic brain injury or normal brain development while very little is available on neurodegenerative diseases (see <xref rid="bib13 bib73" ref-type="bibr">Beaulieu, 2002; Mori and Zhang, 2006</xref> for an overview). It is likely that a degeneration of fibers is associated with a decrease in FA. However, in regions where two fiber tracts are crossing a degeneration of one fiber tract could lead to an increase in FA because the unaffected tract will now dominate and increase WM coherence.</p>
      <p>It should also be kept in mind that some of the observed FA changes (<xref rid="bib95 bib55" ref-type="bibr">Rosas et al., 2006; Klöppel et al., 2008</xref>) could be the effect of misregistration of the images in the presence of neurodegeneration. The WM/GM boundary of the putamen could shift inwards. Areas where HD gene carriers already show WM where the FA is relatively high would be compared to overlapping GM in controls. This could lead to the observed FA increases in the putamen. A similar effect could explain reported decreases in FA in the external capsule. An inward shift of the insular cortex could lead to areas where insular cortex in HD gene carries could overlap with WM in controls. Given that the shift of the boundary correlated with disease progression so would FA values and progression. While this mechanism could explain part of the data it certainly does not explain the complete picture. For example, no FA changes have been found in the caudate which should be equally affected by such misregistration. Interestingly, studies looking at mean diffusivity found changes also in the caudate nucleus (<xref rid="bib66 bib104" ref-type="bibr">Mascalchi et al., 2004; Seppi et al., 2006</xref>) which again argues for region specific degenerative changes.</p>
      <p>As with fMRI, DWI can potentially be useful when preparing or conducting clinical trials. Part of the substantial clinical variability seen in HD may be a reflection of differential involvement of fiber connections between cortical and subcortical regions. For the case of eye-movements, previous work has already shown a correlation between the individual pattern of fiber connections and the level of impairment in voluntary-guided saccades (<xref rid="bib55" ref-type="bibr">Klöppel et al., 2008</xref>). New implementations of fiber tracking have been used to study whole circuits with encouraging reproducibility (<xref rid="bib25" ref-type="bibr">Draganski et al., 2008</xref>).</p>
      <p>While few longitudinal data on DWI are available, encouraging results on the exchangeability of DWI data between imaging centers has been presented (<xref rid="bib56" ref-type="bibr">Landman et al., 2007</xref>) (but see <xref rid="bib77" ref-type="bibr">Ozturk et al., 2008</xref>).</p>
      <p>It is still too early to decide on the usefulness of DWI to either understand the pathophysiology of HD or in the preparation of treatment trials. Currently available data suggest that it can help understanding WM changes already seen in T1-weighted images. When trying to separate PSC from controls using either DWI or T1-weighted imaging, a better separation was achieved using DWI (<xref rid="bib55 bib54" ref-type="bibr">Klöppel et al., 2008, 2009</xref>). A direct comparison is however made difficult as acquisition time was shorter for T1-weighted imaging and because only DWI-weighted data were acquired at a single imaging center. The comparison does however indicate substantial and disease specific changes already in the pre-symptomatic stage of HD to be detectable by DWI.</p>
    </sec>
    <sec id="sec5">
      <title>Imaging: from mice to man</title>
      <p>The identification of the genetic mutation causing HD has led to the development of several animal models of the disease, which have provided fundamental insights into key aspects of disease pathogenesis (<xref rid="bib105 bib85" ref-type="bibr">Sipione and Cattaneo, 2001; Ramaswamy et al., 2007</xref>). Imaging in primates has so far been limited to chemically generated HD models (<xref rid="bib89" ref-type="bibr">Roitberg et al., 2002</xref>) which are unlikely to represent all aspects of the disease. While a transgenic HD model in primates has been reported very recently (<xref rid="bib126" ref-type="bibr">Yang et al., 2008</xref>), most imaging research has focused on mouse models (<xref rid="bib85" ref-type="bibr">Ramaswamy et al., 2007</xref>) and this includes treatment trials (<xref rid="bib29" ref-type="bibr">Ferrante et al., 2002</xref>). Among other things, these models differ in the number of CAG repeats and whether the genetic mutation replaces a wild-type copy of the huntingtin gene (knock-in mice) or has been inserted into the mouse genome, in addition to two normal copies of the mouse HD gene (transgenic mice) (<xref rid="bib85" ref-type="bibr">Ramaswamy et al., 2007</xref>). Although the knock-in mouse should represent a better model of HD in terms of genetics, even in the most rapidly progressing knock-in models end-stage disease does not occur until close to the mouse lifespan (∼2 years) which makes studies using these mice challenging (<xref rid="bib119 bib62" ref-type="bibr">Wheeler et al., 2000; Lin et al., 2001</xref>). However, there is a clear effect of repeat length as more CAG repeats cause substantially more degeneration and clinical signs in both transgenic and knock-in mice (<xref rid="bib114" ref-type="bibr">Van Raamsdonk et al., 2007</xref>).</p>
      <p>Imaging studies have focused on the YAC and the R6/2 mouse models of HD (<xref rid="bib85" ref-type="bibr">Ramaswamy et al., 2007</xref>). Motor symptoms and neuropathological changes in the YAC128 mouse with 128 CAG repeats resemble those of humans. The phenotype of the YAC128 mouse includes a hyperactive phase at the age of 3 months but converts to a hypokinetic phenotype at 6 months compared to wild-type littermates (<xref rid="bib106" ref-type="bibr">Slow et al., 2003</xref>). Interestingly, testing batteries have found that cognitive decline precedes detectable neuropathology as well as motor signs by the age of 2 months (<xref rid="bib113" ref-type="bibr">Van Raamsdonk et al., 2005</xref>). So far, the earliest imaging studies in YAC128 mice have been carried out at the later time point of 8 months (<xref rid="bib60" ref-type="bibr">Lerch et al., 2008b</xref>). Imaging in mice is usually done with a far higher field strength than used in clinical work (7 T and higher in mice vs. 1.5 or 3 T in humans) and scanning times of several hours (compared to around 10 min in humans). At this stage of disease development, comparable to early stage HD in humans, studies report evidence for an enlargement of cortical structures including the right sensorimotor cortex (<xref rid="bib60" ref-type="bibr">Lerch et al., 2008b</xref>). The finding has been repeated with analysis of cortical thickness (<xref rid="bib59" ref-type="bibr">Lerch et al., 2008a</xref>). An increase of volume or cortical thickness was also found bilaterally in the cerebellum, while entorhinal cortex and frontal cortex were enlarged on the left. The study also found decreased volumes of the left inferior colliculus and cerebral peduncle as well as right thalamus and striatum, frontal cortex, paraflocculus and anterior commissure (<xref rid="bib60" ref-type="bibr">Lerch et al., 2008b</xref>).</p>
      <p>Comparison of the findings of imaging studies of the YAC128 mouse model with those in humans reveals a number of similarities: most obviously, striatal degeneration is consistently reported in humans (<xref rid="bib111 bib8 bib48 bib24 bib79" ref-type="bibr">Thieben et al., 2002; Aylward et al., 2004; Kassubek et al., 2004b; Douaud et al., 2006; Paulsen et al., 2006b</xref>). More interestingly, mouse models provide new evidence for cortical enlargement which, as reviewed, has also been suggested in humans (<xref rid="bib79" ref-type="bibr">Paulsen et al., 2006b</xref>). However, while increased cortical volume has been suggested as the result of abnormal development, data from the YAC mouse show a negative correlation between decreasing striatal volume and increasing sensorimotor cortical thickness. Although this could both be a primary effect of the disease, a compensatory mechanism seems more likely.</p>
      <p><xref rid="bib93 bib91 bib94" ref-type="bibr">Rosas and colleagues (2002, 2005, 2008)</xref> have conducted a number of studies on cortical thickness in human HD subjects. While increases in cortical thickness and volume were found in the 8-month-old YAC128 mouse (<xref rid="bib59" ref-type="bibr">Lerch et al., 2008a</xref>), reflecting an early stage of HD, increased thickness in humans was restricted to cingulate areas, with thinning in sensorimotor cortex (<xref rid="bib94" ref-type="bibr">Rosas et al., 2008</xref>).</p>
      <p>Manual outlining and VBM have recently been used to further characterize 18-week-old R6/2 mice with 277 CAG repeats (<xref rid="bib102 bib103" ref-type="bibr">Sawiak et al., 2009a,b</xref>) and produced partially different results. The authors used VBM and located differences in a number of structures including cortex, cerebellum and striatum with gene status without characterizing the directionality. Manual outlining performed by the group found a significantly smaller cortex and striatum in the R6/2 mice while these mice showed a larger globus pallidus. Studies in humans had indicated reduced volume of this structure.</p>
      <p>Those discrepancies could well be attributed to differences between mice and men in brain structure as well as to differences in the underlying genetic model. They underline current difficulties transferring results from mouse models to humans. Improved animal models, possibly including primates, are required, particularly as many drugs are tested in the pre-clinical phase in such models before proceeding to human phase 1 and 2 trials.</p>
    </sec>
    <sec id="sec6">
      <title>The usefulness of imaging as a biomarker</title>
      <sec id="sec6.1">
        <title>Biomarkers in HD</title>
        <p>A biomarker is “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention” (<xref rid="bib15" ref-type="bibr">Biomarkers Definitions Working Group, 2001</xref>). It can be used for diagnosis or staging of disease, as an index of disease progression, or to monitor clinical responses to an intervention. In the case of HD, the genetic mutation is known and this therefore serves as a diagnostic marker for the disease. A useful marker for progression in HD needs to be sensitive to the early stages of the disease, be able to distinguish symptomatic benefit from slowing progression, be associated with a pathogenic process and clinical manifestation of the disease, and be measurable objectively and reliably. In other words it must give a clear picture of part of the disease process. It is then assumed that disease-modifying treatments affecting the clinical characteristics and pathogenesis of a disease, leading to clinical benefit, will similarly effect changes in the biomarker thus leading to a reliable marker of treatment efficacy. In addition, to be useful in a typical clinical trial context, a biomarker needs to be tolerated, non-invasive, reliable and reproducible in multi-center settings.</p>
        <p>Markers that can predict clinical benefits may potentially also serve as surrogate endpoints. Currently typical clinical endpoints in HD are motor onset and death, but trials in which these outcomes were used to assess drug efficacy would take decades. A surrogate endpoint that predicts motor onset (or death) could be used instead, perhaps allowing therapeutic testing in the asymptomatic years prior to motor onset, and also reducing the length of clinical trials.</p>
        <p>However, biomarkers may not always respond to treatment in a predictable manner, as was seen in a recent study for a potential treatment for Alzheimer's disease (AD) in which whole-brain atrophy rates actually increased in patients who responded to an antibody, although at the same time cognitive performance improved slightly (<xref rid="bib32" ref-type="bibr">Fox et al., 2005</xref>). This finding suggests that therapeutic effects may need to be evaluated using a number of different biomarkers simultaneously, in order to provide a more comprehensive picture of the relationships between changes in different modalities.</p>
      </sec>
      <sec id="sec6.2">
        <title>Imaging as a biomarker</title>
        <p>MRI measures appear to have many advantages over other measures such as clinical or cognitive scores as a potential biomarker. Brain volume is unaffected by subject mood or tiredness. MRI can be analyzed blind to subject identity and gene status, and if necessary data collected over a number of sites can be analyzed by a single investigator or fully automated and so measures can be objective and highly reproducible (<xref rid="bib2 bib110" ref-type="bibr">Aylward, 2007; Stonnington et al., 2008</xref>). However, brain volume can be affected by medication or co-morbidity, as well as nutritional factors such as hydration (<xref rid="bib26" ref-type="bibr">Duning et al., 2005</xref>) and so some inter- and intra-individual variability is likely to remain as a result of factors such as these.</p>
        <p>Technical issues such as scanner type and consistency can also affect scan measurements. If scans are acquired over a period of time it is important to ensure that changes in scanner calibration have not biased measurements, although some changes (e.g. in voxel size) can be corrected during post-processing (<xref rid="bib120" ref-type="bibr">Whitwell et al., 2004</xref>). In addition, subjects need to remain still in the scanner for adequate scan quality, which means that in a disease such as HD some subjects will be unsuitable for scanning, and studies will tend to focus on PSC or early affected subjects. Longitudinal studies may risk dropout from the more affected subjects or only be representative of those with less severe motor problems.</p>
      </sec>
      <sec id="sec6.3">
        <title>Imaging biomarkers in HD</title>
        <p>In HD, caudate volume has been suggested as a potential biomarker, because it can be measured objectively, is associated with the major site of pathology in the disease, and predicts motor onset (<xref rid="bib2" ref-type="bibr">Aylward, 2007</xref>). Whole-brain atrophy rate has also been suggested, as it is increased in early HD and measured using a robust, semi-automated technique (<xref rid="bib42" ref-type="bibr">Henley et al., 2006</xref>). Others have pointed out the potential utility of techniques such as VBM (<xref rid="bib24" ref-type="bibr">Douaud et al., 2006</xref>) and cortical thickness measurements in providing indexes of change over time (<xref rid="bib94" ref-type="bibr">Rosas et al., 2008</xref>). Only one study has used imaging in a treatment trial (<xref rid="bib83" ref-type="bibr">Puri et al., 2002</xref>). While the study showed a treatment effect in both imaging and clinical ratings, it should be noted that the number of subjects in each treatment arm was very low (<italic>n</italic>=4 and <italic>n</italic>=3, respectively) and that imaging in late stage HD is very challenging.</p>
        <p>Recently, multivariate methods combining information from a number of characteristic degenerative changes have caused increasing interest. While these methods are used primarily to detect subtle degeneration in PSC (<xref rid="bib54" ref-type="bibr">Klöppel et al., 2009</xref>), they could prove useful to rate individual levels of degenerative change before inclusion in a treatment trial (<xref rid="bib115" ref-type="bibr">Vemuri et al., 2008</xref>). Their usefulness as a sensitive tool to detect disease progression remains to be shown.</p>
        <p><xref rid="bib16" ref-type="bibr">Bohanna et al. (2008)</xref> suggested multimodal imaging with the idea that structural MRI would be most sensitive to slow degenerative processes while fMRI could aid in monitoring pharmacodynamics. They also suggested a combination with DWI to test for microstructural changes (<xref rid="bib16" ref-type="bibr">Bohanna et al., 2008</xref>). While this approach constitutes a methodological challenge, it could facilitate the interpretation of results. As described for the case of AD (<xref rid="bib32" ref-type="bibr">Fox et al., 2005</xref>), increasing atrophy rates do not necessarily represent increasing neurodegeneration. Similarly, a “normalization” of compensatory hyperactivation in HD found by fMRI could mean a true normalization, but could also mean continuing degeneration.</p>
        <p>Another issue, which is relevant to all potential markers of HD, is that motor onset is itself subjective and does not fully reflect the insidious onset of symptoms across multiple domains, which is now known to occur in HD. An ideal surrogate endpoint should fully predict existing clinical outcomes, but this will depend on how well the existing clinical outcome measures reflect the disease in the first place, as well as the variability of the surrogate measure itself.</p>
        <p>It is clear that more work is needed to measure change in the natural course of HD, and to determine better indicators of onset and progression of the disease. This is particularly true for PSC and early affected subjects, those who are most likely to enter clinical trials and benefit from disease-modifying treatments at an earlier stage in the disease process. A number of relatively small treatment trials using imaging as an outcome measure are currently being carried out. In addition, large multi-center studies such as TRACK-HD (<ext-link xlink:href="http://www.track-hd.net" ext-link-type="uri">http://www.track-hd.net</ext-link>) and PREDICT-HD (<xref rid="bib80" ref-type="bibr">Paulsen et al., 2008</xref>) are ongoing and are likely to provide new insights into both the pathophysiology of HD and its measurement.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors would like to thank Gillian Bates for editing the section on mice models. This work was supported by the Wellcome Trust (grant 075,696 2/04/2 to R.F. and S.J.T.). N.H. and S.H. were supported by CHDI, Inc. Part of this work was undertaken at UCLH/UCH which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashburner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Friston</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Voxel-based morphometry—the methods</article-title>
          <source>Neuroimage</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>805</fpage>
          <lpage>821</lpage>
          <pub-id pub-id-type="pmid">10860804</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
          </person-group>
          <article-title>Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease</article-title>
          <source>Brain Res Bull</source>
          <year>2007</year>
          <volume>72</volume>
          <fpage>152</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">17352939</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>N.B.</given-names>
            </name>
            <name>
              <surname>Bylsma</surname>
              <given-names>F.W.</given-names>
            </name>
            <name>
              <surname>Wagster</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Sherr</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Feeney</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rosenblatt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Frontal lobe volume in patients with Huntington's disease</article-title>
          <source>Neurology</source>
          <year>1998</year>
          <volume>50</volume>
          <fpage>252</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="pmid">9443488</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Codori</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Mangus</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>G.J.</given-names>
            </name>
          </person-group>
          <article-title>Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons</article-title>
          <source>Neurology</source>
          <year>1994</year>
          <volume>44</volume>
          <fpage>823</fpage>
          <lpage>828</lpage>
          <pub-id pub-id-type="pmid">8190282</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Codori</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Basal ganglia volume and proximity to onset in presymptomatic Huntington disease</article-title>
          <source>Arch Neurol</source>
          <year>1996</year>
          <volume>53</volume>
          <fpage>1293</fpage>
          <lpage>1296</lpage>
          <pub-id pub-id-type="pmid">8970459</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Codori</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Rosenblatt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sherr</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stine</surname>
              <given-names>O.C.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease</article-title>
          <source>Mov Disord</source>
          <year>2000</year>
          <volume>15</volume>
          <fpage>552</fpage>
          <lpage>560</lpage>
          <pub-id pub-id-type="pmid">10830423</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Stine</surname>
              <given-names>O.C.</given-names>
            </name>
            <name>
              <surname>Ranen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sherr</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Bylsma</surname>
              <given-names>F.W.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Longitudinal change in basal ganglia volume in patients with Huntington's disease</article-title>
          <source>Neurology</source>
          <year>1997</year>
          <volume>48</volume>
          <fpage>394</fpage>
          <lpage>399</lpage>
          <pub-id pub-id-type="pmid">9040728</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Sparks</surname>
              <given-names>B.F.</given-names>
            </name>
            <name>
              <surname>Field</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Yallapragada</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Shpritz</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Rosenblatt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gourley</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Onset and rate of striatal atrophy in preclinical Huntington disease</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>66</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">15249612</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Backman</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Robins-Wahlin</surname>
              <given-names>T.B.</given-names>
            </name>
            <name>
              <surname>Lundin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ginovart</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Farde</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes</article-title>
          <source>Brain</source>
          <year>1997</year>
          <volume>120</volume>
          <issue>Pt 12</issue>
          <fpage>2207</fpage>
          <lpage>2217</lpage>
          <pub-id pub-id-type="pmid">9448576</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bamford</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Caine</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Kido</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Shoulson</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates</article-title>
          <source>Neurology</source>
          <year>1995</year>
          <volume>45</volume>
          <fpage>1867</fpage>
          <lpage>1873</lpage>
          <pub-id pub-id-type="pmid">7477984</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bamford</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Caine</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Kido</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Plassche</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Shoulson</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study</article-title>
          <source>Neurology</source>
          <year>1989</year>
          <volume>39</volume>
          <fpage>796</fpage>
          <lpage>801</lpage>
          <pub-id pub-id-type="pmid">2524678</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrios</surname>
              <given-names>F.A.</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Favila</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Salgado</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Fernandez-Ruiz</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Olfaction and neurodegeneration in HD</article-title>
          <source>Neuroreport</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>73</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">17259864</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beaulieu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>The basis of anisotropic water diffusion in the nervous system—a technical review</article-title>
          <source>NMR Biomed</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>435</fpage>
          <lpage>455</lpage>
          <pub-id pub-id-type="pmid">12489094</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beglinger</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Nopoulos</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Jorge</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Langbehn</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Mikos</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Duff</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>White matter volume and cognitive dysfunction in early Huntington's disease</article-title>
          <source>Cogn Behav Neurol</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>102</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">15970729</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <collab>Biomarkers Definitions Working Group</collab>
          </person-group>
          <article-title>Biomarkers and surrogate endpoints: preferred definitions and conceptual framework</article-title>
          <source>Clin Pharmacol Ther</source>
          <year>2001</year>
          <volume>69</volume>
          <fpage>89</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">11240971</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bohanna</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Georgiou-Karistianis</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hannan</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>G.F.</given-names>
            </name>
          </person-group>
          <article-title>Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease</article-title>
          <source>Brain Res Rev</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>209</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">18486229</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosnell</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wegner</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kincses</surname>
              <given-names>Z.T.</given-names>
            </name>
            <name>
              <surname>Korteweg</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Agosta</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>De Stefano</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gass</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Johansen-Berg</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kappos</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Barkhof</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Manfredonia</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Montalban</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Palace</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rocca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Enzinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ropele</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rovira</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yousry</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Whitcher</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Filippi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Reproducibility of fMRI in the clinical setting: implications for trial designs</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>42</volume>
          <fpage>603</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="pmid">18579411</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bylsma</surname>
              <given-names>F.W.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Rothlind</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gow</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Impaired source memory in Huntington's disease and its relation to basal ganglia atrophy</article-title>
          <source>J Clin Exp Neuropsychol</source>
          <year>1995</year>
          <volume>17</volume>
          <fpage>868</fpage>
          <lpage>877</lpage>
          <pub-id pub-id-type="pmid">8847393</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calhoun</surname>
              <given-names>V.D.</given-names>
            </name>
            <name>
              <surname>Kiehl</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks</article-title>
          <source>Hum Brain Mapp</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>828</fpage>
          <lpage>838</lpage>
          <pub-id pub-id-type="pmid">18438867</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calhoun</surname>
              <given-names>V.D.</given-names>
            </name>
            <name>
              <surname>Maciejewski</surname>
              <given-names>P.K.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Kiehl</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Temporal lobe and “default” hemodynamic brain modes discriminate between schizophrenia and bipolar disorder</article-title>
          <source>Hum Brain Mapp</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>1265</fpage>
          <lpage>1275</lpage>
          <pub-id pub-id-type="pmid">17894392</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciarmiello</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cannella</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lastoria</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Simonelli</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Frati</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rubinsztein</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Squitieri</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease</article-title>
          <source>J Nucl Med</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>215</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">16455626</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deckel</surname>
              <given-names>A.W.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide and nitric oxide synthase in Huntington's disease</article-title>
          <source>J Neurosci Res</source>
          <year>2001</year>
          <volume>64</volume>
          <fpage>99</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">11288139</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deckel</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Duckrow</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease</article-title>
          <source>Neurology</source>
          <year>1998</year>
          <volume>51</volume>
          <fpage>1576</fpage>
          <lpage>1583</lpage>
          <pub-id pub-id-type="pmid">9855504</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Douaud</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Gaura</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Lethimonnier</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Maroy</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Verny</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Krystkowiak</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Damier</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bachoud-Levi</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Hantraye</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Remy</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study</article-title>
          <source>Neuroimage</source>
          <year>2006</year>
          <volume>32</volume>
          <fpage>1562</fpage>
          <lpage>1575</lpage>
          <pub-id pub-id-type="pmid">16875847</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Draganski</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kherif</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Klöppel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Deichmann</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ashburner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Frackowiak</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for segregated and integrative connectivity patterns in the human basal ganglia</article-title>
          <source>J Neurosci</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>7143</fpage>
          <lpage>7152</lpage>
          <pub-id pub-id-type="pmid">18614684</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duning</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kloska</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Steinstrater</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Kugel</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Heindel</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Knecht</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Dehydration confounds the assessment of brain atrophy</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>548</fpage>
          <lpage>550</lpage>
          <pub-id pub-id-type="pmid">15699394</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feigin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ghilardi</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Carbon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Guttman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Ghez</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Eidelberg</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Preclinical Huntington's disease: compensatory brain responses during learning</article-title>
          <source>Ann Neurol</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>53</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">16261565</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fennema-Notestine</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Archibald</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Corey-Bloom</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Peavy</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Gamst</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Salmon</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Jernigan</surname>
              <given-names>T.L.</given-names>
            </name>
          </person-group>
          <article-title>In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>989</fpage>
          <lpage>995</lpage>
          <pub-id pub-id-type="pmid">15452288</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrante</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Andreassen</surname>
              <given-names>O.A.</given-names>
            </name>
            <name>
              <surname>Dedeoglu</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>M.F.</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease</article-title>
          <source>J Neurosci</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>1592</fpage>
          <lpage>1599</lpage>
          <pub-id pub-id-type="pmid">11880489</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrante</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Gutekunst</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Persichetti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>McNeil</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Kowall</surname>
              <given-names>N.W.</given-names>
            </name>
            <name>
              <surname>Gusella</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>3052</fpage>
          <lpage>3063</lpage>
          <pub-id pub-id-type="pmid">9096140</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fischl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Measuring the thickness of the human cerebral cortex from magnetic resonance images</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>11050</fpage>
          <lpage>11055</lpage>
          <pub-id pub-id-type="pmid">10984517</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fox</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Gilman</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rossor</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Koller</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>1563</fpage>
          <lpage>1572</lpage>
          <pub-id pub-id-type="pmid">15883317</pub-id>
        </citation>
      </ref>
      <ref id="bib33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freeborough</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>N.C.</given-names>
            </name>
          </person-group>
          <article-title>The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI</article-title>
          <source>IEEE Trans Med Imaging</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>623</fpage>
          <lpage>629</lpage>
          <pub-id pub-id-type="pmid">9368118</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georgiou-Karistianis</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sritharan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Farrow</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cunnington</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Stout</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bradshaw</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Churchyard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brawn</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Chua</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Thiruvady</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Increased cortical recruitment in Huntington's disease using a Simon task</article-title>
          <source>Neuropsychologia</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>1791</fpage>
          <lpage>1800</lpage>
          <pub-id pub-id-type="pmid">17321554</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gutekunst</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mulroy</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Kuemmerle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rye</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.J.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology</article-title>
          <source>J Neurosci</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>2522</fpage>
          <lpage>2534</lpage>
          <pub-id pub-id-type="pmid">10087066</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gutekunst</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Norflus</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>The neuropathology of Huntington's disease</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Bates</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <source>Huntington's disease</source>
          <year>2002</year>
          <publisher-name>Oxford Monographs on Medical Genetics</publisher-name>
          <publisher-loc>Oxford</publisher-loc>
          <fpage>251</fpage>
          <lpage>270</lpage>
        </citation>
      </ref>
      <ref id="bib37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halliday</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>McRitchie</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Double</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Trent</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>McCusker</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Regional specificity of brain atrophy in Huntington's disease</article-title>
          <source>Exp Neurol</source>
          <year>1998</year>
          <volume>154</volume>
          <fpage>663</fpage>
          <lpage>672</lpage>
          <pub-id pub-id-type="pmid">9878201</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Peyser</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Roberts-Twillie</surname>
              <given-names>J.V.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Folstein</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease</article-title>
          <source>Arch Neurol</source>
          <year>1996</year>
          <volume>53</volume>
          <fpage>316</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">8929153</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Codori</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bedi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease</article-title>
          <source>Brain</source>
          <year>1999</year>
          <volume>122</volume>
          <issue>Pt 9</issue>
          <fpage>1667</fpage>
          <lpage>1678</lpage>
          <pub-id pub-id-type="pmid">10468506</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Peyser</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Barta</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Chase</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Folstein</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease</article-title>
          <source>Ann Neurol</source>
          <year>1992</year>
          <volume>31</volume>
          <fpage>69</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">1531910</pub-id>
        </citation>
      </ref>
      <ref id="bib41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henley</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>G.P.</given-names>
            </name>
            <name>
              <surname>Tabrizi</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Biomarkers for neurodegenerative diseases</article-title>
          <source>Curr Opin Neurol</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>698</fpage>
          <lpage>705</lpage>
          <pub-id pub-id-type="pmid">16280682</pub-id>
        </citation>
      </ref>
      <ref id="bib42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henley</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Frost</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>MacManus</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Tabrizi</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Increased rate of whole-brain atrophy over 6 months in early Huntington disease</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>694</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">16924028</pub-id>
        </citation>
      </ref>
      <ref id="bib43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henley</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Hobbs</surname>
              <given-names>N.Z.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Frost</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Scahill</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Ridgway</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>MacManus</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Tabrizi</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Defective emotion recognition in early HD is neuropsychologically and anatomically generic</article-title>
          <source>Neuropsychologia</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>2152</fpage>
          <lpage>2160</lpage>
          <pub-id pub-id-type="pmid">18407301</pub-id>
        </citation>
      </ref>
      <ref id="bib44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hennenlotter</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schroeder</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Erhard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Haslinger</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Stahl</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Weindl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>von Einsiedel</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Ceballos-Baumann</surname>
              <given-names>A.O.</given-names>
            </name>
          </person-group>
          <article-title>Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease</article-title>
          <source>Brain</source>
          <year>2004</year>
          <volume>127</volume>
          <fpage>1446</fpage>
          <lpage>1453</lpage>
          <pub-id pub-id-type="pmid">15090475</pub-id>
        </citation>
      </ref>
      <ref id="bib45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Im</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Lyttelton</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.I.</given-names>
            </name>
          </person-group>
          <article-title>Brain size and cortical structure in the adult human brain</article-title>
          <source>Cereb Cortex</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>2181</fpage>
          <lpage>2191</lpage>
          <pub-id pub-id-type="pmid">18234686</pub-id>
        </citation>
      </ref>
      <ref id="bib46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Symms</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Cercignani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>The effect of filter size on VBM analyses of DT-MRI data</article-title>
          <source>Neuroimage</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>546</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">15907311</pub-id>
        </citation>
      </ref>
      <ref id="bib47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassubek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bernhard Landwehrmeyer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Juengling</surname>
              <given-names>F.D.</given-names>
            </name>
            <name>
              <surname>Muche</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Schuller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Weindl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Peinemann</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study</article-title>
          <source>Neuroreport</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>363</fpage>
          <lpage>365</lpage>
          <pub-id pub-id-type="pmid">15076769</pub-id>
        </citation>
      </ref>
      <ref id="bib48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassubek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Juengling</surname>
              <given-names>F.D.</given-names>
            </name>
            <name>
              <surname>Kioschies</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Henkel</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Karitzky</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Andrich</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Saft</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kraus</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aschoff</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ludolph</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>G.B.</given-names>
            </name>
          </person-group>
          <article-title>Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2004</year>
          <volume>75</volume>
          <fpage>213</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">14742591</pub-id>
        </citation>
      </ref>
      <ref id="bib49">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassubek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Juengling</surname>
              <given-names>F.D.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>G.B.</given-names>
            </name>
          </person-group>
          <article-title>Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis</article-title>
          <source>Cereb Cortex</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>846</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="pmid">15459079</pub-id>
        </citation>
      </ref>
      <ref id="bib50">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Beg</surname>
              <given-names>M.F.</given-names>
            </name>
          </person-group>
          <article-title>FreeSurfer-initiated fully-automated subcortical brain segmentation in MRI using large deformation diffeomorphic metric mapping</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>41</volume>
          <fpage>735</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="pmid">18455931</pub-id>
        </citation>
      </ref>
      <ref id="bib51">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Reading</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Brashers-Krug</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Calhoun</surname>
              <given-names>V.D.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
          </person-group>
          <article-title>Functional MRI study of a serial reaction time task in Huntington's disease</article-title>
          <source>Psychiatry Res</source>
          <year>2004</year>
          <volume>131</volume>
          <fpage>23</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">15246452</pub-id>
        </citation>
      </ref>
      <ref id="bib52">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kipps</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Duggins</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Mahant</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ashburner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>McCusker</surname>
              <given-names>E.A.</given-names>
            </name>
          </person-group>
          <article-title>Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2005</year>
          <volume>76</volume>
          <fpage>650</fpage>
          <lpage>655</lpage>
          <pub-id pub-id-type="pmid">15834021</pub-id>
        </citation>
      </ref>
      <ref id="bib53">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kipps</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Duggins</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>McCusker</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Calder</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Disgust and happiness recognition correlate with anteroventral insula and amygdala volume respectively in preclinical Huntington's disease</article-title>
          <source>J Cogn Neurosci</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>1206</fpage>
          <lpage>1217</lpage>
          <pub-id pub-id-type="pmid">17583995</pub-id>
        </citation>
      </ref>
      <ref id="bib54">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klöppel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Draganski</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Kienzle</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Tabrizi</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Ashburner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Frackowiak</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease</article-title>
          <source>Neurology</source>
          <year>2009</year>
          <volume>72</volume>
          <fpage>426</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">19188573</pub-id>
        </citation>
      </ref>
      <ref id="bib55">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klöppel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Draganski</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Golding</surname>
              <given-names>C.V.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nagy</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Hicks</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Kennard</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Tabrizi</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Frackowiak</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease</article-title>
          <source>Brain</source>
          <year>2008</year>
          <volume>131</volume>
          <fpage>196</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">18056161</pub-id>
        </citation>
      </ref>
      <ref id="bib56">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landman</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T</article-title>
          <source>Neuroimage</source>
          <year>2007</year>
          <volume>36</volume>
          <fpage>1123</fpage>
          <lpage>1138</lpage>
          <pub-id pub-id-type="pmid">17532649</pub-id>
        </citation>
      </ref>
      <ref id="bib57">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawrence</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Sahakian</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Hodges</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Rosser</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Robbins</surname>
              <given-names>T.W.</given-names>
            </name>
          </person-group>
          <article-title>Executive and mnemonic functions in early Huntington's disease</article-title>
          <source>Brain</source>
          <year>1996</year>
          <volume>119</volume>
          <issue>Pt 5</issue>
          <fpage>1633</fpage>
          <lpage>1645</lpage>
          <pub-id pub-id-type="pmid">8931586</pub-id>
        </citation>
      </ref>
      <ref id="bib58">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lemiere</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Decruyenaere</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Evers-Kiebooms</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vandenbussche</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Dom</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation—a longitudinal follow-up study</article-title>
          <source>J Neurol</source>
          <year>2004</year>
          <volume>251</volume>
          <fpage>935</fpage>
          <lpage>942</lpage>
          <pub-id pub-id-type="pmid">15316797</pub-id>
        </citation>
      </ref>
      <ref id="bib59">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lerch</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Dorr</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Spring</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Sled</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Henkelman</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>41</volume>
          <fpage>243</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="pmid">18387826</pub-id>
        </citation>
      </ref>
      <ref id="bib60">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lerch</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Spring</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bertram</surname>
              <given-names>L.N.</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Henkelman</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Automated deformation analysis in the YAC128 Huntington disease mouse model</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>39</volume>
          <fpage>32</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">17942324</pub-id>
        </citation>
      </ref>
      <ref id="bib61">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Cools</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Robbins</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Dove</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease</article-title>
          <source>Neuropsychologia</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>645</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="pmid">12591022</pub-id>
        </citation>
      </ref>
      <ref id="bib62">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Tallaksen-Greene</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Cearley</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Crouse</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.J.</given-names>
            </name>
            <name>
              <surname>Albin</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Detloff</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Neurological abnormalities in a knock-in mouse model of Huntington's disease</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>137</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">11152661</pub-id>
        </citation>
      </ref>
      <ref id="bib63">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lundervold</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Reinvang</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Variability in cognitive function among persons at high genetic risk of Huntington's disease</article-title>
          <source>Acta Neurol Scand</source>
          <year>1995</year>
          <volume>91</volume>
          <fpage>462</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">7572041</pub-id>
        </citation>
      </ref>
      <ref id="bib64">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Eidelberg</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease</article-title>
          <source>Mol Imaging Biol</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>223</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">17334854</pub-id>
        </citation>
      </ref>
      <ref id="bib65">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magnotta</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Andreasen</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>O'Leary</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Yuh</surname>
              <given-names>W.T.</given-names>
            </name>
            <name>
              <surname>Heckel</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Structural MR image processing using the BRAINS2 toolbox</article-title>
          <source>Comput Med Imaging Graph</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>251</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">12074920</pub-id>
        </citation>
      </ref>
      <ref id="bib66">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mascalchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lolli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Della Nave</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Tessa</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Petralli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Gavazzi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Politi</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Macucci</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Filippi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Piacentini</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain</article-title>
          <source>Radiology</source>
          <year>2004</year>
          <volume>232</volume>
          <fpage>867</fpage>
          <lpage>873</lpage>
          <pub-id pub-id-type="pmid">15215553</pub-id>
        </citation>
      </ref>
      <ref id="bib67">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Middleton</surname>
              <given-names>F.A.</given-names>
            </name>
            <name>
              <surname>Strick</surname>
              <given-names>P.L.</given-names>
            </name>
          </person-group>
          <article-title>Basal ganglia and cerebellar loops: motor and cognitive circuits</article-title>
          <source>Brain Res Brain Res Rev</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>236</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">10719151</pub-id>
        </citation>
      </ref>
      <ref id="bib68">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Petrides</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mejia-Constain</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Strafella</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Cortical activity in Parkinson's disease during executive processing depends on striatal involvement</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <fpage>233</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="pmid">17121746</pub-id>
        </citation>
      </ref>
      <ref id="bib69">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Petrides</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Strafella</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Worsley</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Doyon</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Functional role of the basal ganglia in the planning and execution of actions</article-title>
          <source>Ann Neurol</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>257</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">16437582</pub-id>
        </citation>
      </ref>
      <ref id="bib70">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Dagher</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A neural model of working memory processes in normal subjects, Parkinson's disease and schizophrenia for fMRI design and predictions</article-title>
          <source>Neural Netw</source>
          <year>2000</year>
          <volume>13</volume>
          <fpage>953</fpage>
          <lpage>973</lpage>
          <pub-id pub-id-type="pmid">11156204</pub-id>
        </citation>
      </ref>
      <ref id="bib71">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montoya</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Menear</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lepage</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Brain imaging and cognitive dysfunctions in Huntington's disease</article-title>
          <source>J Psychiatry Neurosci</source>
          <year>2006</year>
          <volume>31</volume>
          <fpage>21</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">16496032</pub-id>
        </citation>
      </ref>
      <ref id="bib72">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Crain</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Chacko</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>van Zijl</surname>
              <given-names>P.C.</given-names>
            </name>
          </person-group>
          <article-title>Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging</article-title>
          <source>Ann Neurol</source>
          <year>1999</year>
          <volume>45</volume>
          <fpage>265</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">9989633</pub-id>
        </citation>
      </ref>
      <ref id="bib73">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Principles of diffusion tensor imaging and its applications to basic neuroscience research</article-title>
          <source>Neuron</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>527</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="pmid">16950152</pub-id>
        </citation>
      </ref>
      <ref id="bib74">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muhlau</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Weindl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wohlschlager</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Gaser</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Stadtler</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Valet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zimmer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kassubek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Peinemann</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease</article-title>
          <source>J Neural Transm</source>
          <year>2007</year>
          <volume>114</volume>
          <fpage>367</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="pmid">17024326</pub-id>
        </citation>
      </ref>
      <ref id="bib75">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Magnotta</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Mikos</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Paulson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Andreasen</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Morphology of the cerebral cortex in preclinical Huntington's disease</article-title>
          <source>Am J Psychiatry</source>
          <year>2007</year>
          <volume>164</volume>
          <fpage>1428</fpage>
          <lpage>1434</lpage>
          <pub-id pub-id-type="pmid">17728429</pub-id>
        </citation>
      </ref>
      <ref id="bib76">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Deutsch</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Seidman</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Hodge</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Makris</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Caviness</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Frazier</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods</article-title>
          <source>Harv Rev Psychiatry</source>
          <year>2006</year>
          <volume>14</volume>
          <fpage>141</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="pmid">16787886</pub-id>
        </citation>
      </ref>
      <ref id="bib77">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozturk</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sasson</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Landman</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>da Motta</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Aralasmak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yousem</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Regional differences in diffusion tensor imaging measurements: assessment of intrarater and interrater variability</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>1124</fpage>
          <lpage>1127</lpage>
          <pub-id pub-id-type="pmid">18356471</pub-id>
        </citation>
      </ref>
      <ref id="bib78">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stout</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Langbehn</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Guttman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nance</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kieburtz</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Oakes</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Shoulson</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kayson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Penziner</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Preparing for preventive clinical trials: the PREDICT-HD study</article-title>
          <source>Arch Neurol</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>883</fpage>
          <lpage>890</lpage>
          <pub-id pub-id-type="pmid">16769871</pub-id>
        </citation>
      </ref>
      <ref id="bib79">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Magnotta</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Mikos</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Paulson</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Penziner</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Andreasen</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Nopoulos</surname>
              <given-names>P.C.</given-names>
            </name>
          </person-group>
          <article-title>Brain structure in preclinical Huntington's disease</article-title>
          <source>Biol Psychiatry</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>57</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">16112655</pub-id>
        </citation>
      </ref>
      <ref id="bib80">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Langbehn</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Stout</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Nance</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Guttman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Beglinger</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Duff</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kayson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Biglan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shoulson</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Oakes</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Detection of Huntington's disease decades before diagnosis: the PREDICT-HD study</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2008</year>
          <volume>79</volume>
          <fpage>874</fpage>
          <lpage>880</lpage>
          <pub-id pub-id-type="pmid">18096682</pub-id>
        </citation>
      </ref>
      <ref id="bib81">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Zimbelman</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Hinton</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Langbehn</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Leveroni</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Benjamin</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>1715</fpage>
          <lpage>1721</lpage>
          <pub-id pub-id-type="pmid">15569736</pub-id>
        </citation>
      </ref>
      <ref id="bib82">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peinemann</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schuller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pohl</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Weindl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kassubek</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study</article-title>
          <source>J Neurol Sci</source>
          <year>2005</year>
          <volume>239</volume>
          <fpage>11</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">16185716</pub-id>
        </citation>
      </ref>
      <ref id="bib83">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puri</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Bydder</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Counsell</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Corridan</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Hajnal</surname>
              <given-names>J.V.</given-names>
            </name>
            <name>
              <surname>Appel</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>McKee</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Vaddadi</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Horrobin</surname>
              <given-names>D.F.</given-names>
            </name>
          </person-group>
          <article-title>MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment</article-title>
          <source>Neuroreport</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>123</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="pmid">11924873</pub-id>
        </citation>
      </ref>
      <ref id="bib84">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajah</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>D'Esposito</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory</article-title>
          <source>Brain</source>
          <year>2005</year>
          <volume>128</volume>
          <fpage>1964</fpage>
          <lpage>1983</lpage>
          <pub-id pub-id-type="pmid">16049041</pub-id>
        </citation>
      </ref>
      <ref id="bib85">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramaswamy</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>McBride</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Kordower</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Animal models of Huntington's disease</article-title>
          <source>ILAR J</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>356</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="pmid">17712222</pub-id>
        </citation>
      </ref>
      <ref id="bib86">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reading</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Dziorny</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Peroutka</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Schreiber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gourley</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Yallapragada</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Rosenblatt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Pekar</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Pearlson</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bassett</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Functional brain changes in presymptomatic Huntington's disease</article-title>
          <source>Ann Neurol</source>
          <year>2004</year>
          <volume>55</volume>
          <fpage>879</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="pmid">15174024</pub-id>
        </citation>
      </ref>
      <ref id="bib87">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reading</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Yassa</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dziorny</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Gourley</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Yallapragada</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Rosenblatt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>van Zijl</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bassett</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study</article-title>
          <source>Psychiatry Res</source>
          <year>2005</year>
          <volume>140</volume>
          <fpage>55</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">16199141</pub-id>
        </citation>
      </ref>
      <ref id="bib88">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridgway</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Henley</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Rohrer</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Scahill</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>N.C.</given-names>
            </name>
          </person-group>
          <article-title>Ten simple rules for reporting voxel-based morphometry studies</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>40</volume>
          <fpage>1429</fpage>
          <lpage>1435</lpage>
          <pub-id pub-id-type="pmid">18314353</pub-id>
        </citation>
      </ref>
      <ref id="bib89">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roitberg</surname>
              <given-names>B.Z.</given-names>
            </name>
            <name>
              <surname>Emborg</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Sramek</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Palfi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kordower</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease</article-title>
          <source>Neurosurgery</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>137</fpage>
          <lpage>145</lpage>
          <comment>discussion: 145–136</comment>
          <pub-id pub-id-type="pmid">11844244</pub-id>
        </citation>
      </ref>
      <ref id="bib90">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.I.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Makris</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Patti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Seidman</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Koroshetz</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>Striatal volume loss in HD as measured by MRI and the influence of CAG repeat</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>1025</fpage>
          <lpage>1028</lpage>
          <pub-id pub-id-type="pmid">11571328</pub-id>
        </citation>
      </ref>
      <ref id="bib91">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Hevelone</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Zaleta</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Greve</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Salat</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Fischl</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Regional cortical thinning in preclinical Huntington disease and its relationship to cognition</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>745</fpage>
          <lpage>747</lpage>
          <pub-id pub-id-type="pmid">16157910</pub-id>
        </citation>
      </ref>
      <ref id="bib92">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Koroshetz</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.I.</given-names>
            </name>
            <name>
              <surname>Skeuse</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vangel</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cudkowicz</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Caplan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Marek</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Seidman</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Makris</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>1615</fpage>
          <lpage>1620</lpage>
          <pub-id pub-id-type="pmid">12771251</pub-id>
        </citation>
      </ref>
      <ref id="bib93">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Glessner</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Salat</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>van der Kouwe</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Fischl</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Regional and progressive thinning of the cortical ribbon in Huntington's disease</article-title>
          <source>Neurology</source>
          <year>2002</year>
          <volume>58</volume>
          <fpage>695</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="pmid">11889230</pub-id>
        </citation>
      </ref>
      <ref id="bib94">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Salat</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Zaleta</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Pappu</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Fischl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Greve</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hevelone</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity</article-title>
          <source>Brain</source>
          <year>2008</year>
          <volume>131</volume>
          <fpage>1057</fpage>
          <lpage>1068</lpage>
          <pub-id pub-id-type="pmid">18337273</pub-id>
        </citation>
      </ref>
      <ref id="bib95">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Tuch</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Hevelone</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Zaleta</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Vangel</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Salat</surname>
              <given-names>D.H.</given-names>
            </name>
          </person-group>
          <article-title>Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures</article-title>
          <source>Mov Disord</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>1317</fpage>
          <lpage>1325</lpage>
          <pub-id pub-id-type="pmid">16755582</pub-id>
        </citation>
      </ref>
      <ref id="bib96">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruocco</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Bonilha</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Lopes-Cendes</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Cendes</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2008</year>
          <volume>79</volume>
          <fpage>130</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="pmid">17615168</pub-id>
        </citation>
      </ref>
      <ref id="bib97">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rypma</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>D'Esposito</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The influence of working-memory demand and subject performance on prefrontal cortical activity</article-title>
          <source>J Cogn Neurosci</source>
          <year>2002</year>
          <volume>14</volume>
          <fpage>721</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="pmid">12167257</pub-id>
        </citation>
      </ref>
      <ref id="bib98">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rypma</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>D'Esposito</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The roles of prefrontal brain regions in components of working memory: effects of memory load and individual differences</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>6558</fpage>
          <lpage>6563</lpage>
          <pub-id pub-id-type="pmid">10339627</pub-id>
        </citation>
      </ref>
      <ref id="bib99">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rypma</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Prabhakaran</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Desmond</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Glover</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Gabrieli</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Load-dependent roles of frontal brain regions in the maintenance of working memory</article-title>
          <source>Neuroimage</source>
          <year>1999</year>
          <volume>9</volume>
          <fpage>216</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="pmid">9927550</pub-id>
        </citation>
      </ref>
      <ref id="bib100">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saft</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schuttke</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Beste</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Andrich</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Heindel</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Pfleiderer</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease</article-title>
          <source>Neuropsychologia</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>1279</fpage>
          <lpage>1289</lpage>
          <pub-id pub-id-type="pmid">18221758</pub-id>
        </citation>
      </ref>
      <ref id="bib101">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sapp</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chase</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bhide</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Penney</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Vonsattel</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Aronin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>DiFiglia</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Huntingtin localization in brains of normal and Huntington's disease patients</article-title>
          <source>Ann Neurol</source>
          <year>1997</year>
          <volume>42</volume>
          <fpage>604</fpage>
          <lpage>612</lpage>
          <pub-id pub-id-type="pmid">9382472</pub-id>
        </citation>
      </ref>
      <ref id="bib102">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawiak</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>N.I.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>T.A.</given-names>
            </name>
          </person-group>
          <article-title>Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease</article-title>
          <source>Neurobiol Dis</source>
          <year>2009</year>
          <volume>33</volume>
          <fpage>12</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">18930823</pub-id>
        </citation>
      </ref>
      <ref id="bib103">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawiak</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>N.I.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>T.A.</given-names>
            </name>
          </person-group>
          <article-title>Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry</article-title>
          <source>Neurobiol Dis</source>
          <year>2009</year>
          <volume>33</volume>
          <fpage>20</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">18930824</pub-id>
        </citation>
      </ref>
      <ref id="bib104">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seppi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Schocke</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Mair</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Esterhammer</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Weirich-Schwaiger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Utermann</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Egger</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Brenneis</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Granata</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Boesch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Poewe</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wenning</surname>
              <given-names>G.K.</given-names>
            </name>
          </person-group>
          <article-title>Diffusion-weighted imaging in Huntington's disease</article-title>
          <source>Mov Disord</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>1043</fpage>
          <lpage>1047</lpage>
          <pub-id pub-id-type="pmid">16570300</pub-id>
        </citation>
      </ref>
      <ref id="bib105">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sipione</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cattaneo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Modeling Huntington's disease in cells, flies, and mice</article-title>
          <source>Mol Neurobiol</source>
          <year>2001</year>
          <volume>23</volume>
          <fpage>21</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">11642542</pub-id>
        </citation>
      </ref>
      <ref id="bib106">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Slow</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>van Raamsdonk</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bissada</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hossain</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.J.</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Gutekunst</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Leavitt</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease</article-title>
          <source>Hum Mol Genet</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>1555</fpage>
          <lpage>1567</lpage>
          <pub-id pub-id-type="pmid">12812983</pub-id>
        </citation>
      </ref>
      <ref id="bib107">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snowden</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Craufurd</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Neary</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Psychomotor, executive, and memory function in preclinical Huntington's disease</article-title>
          <source>J Clin Exp Neuropsychol</source>
          <year>2002</year>
          <volume>24</volume>
          <fpage>133</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">11992196</pub-id>
        </citation>
      </ref>
      <ref id="bib108">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solomon</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Stout</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Langbehn</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Beglinger</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Kieburtz</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kayson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Julian-Baros</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Duff</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Guttman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nance</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Oakes</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Shoulson</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Penziner</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Verbal episodic memory declines prior to diagnosis in Huntington's disease</article-title>
          <source>Neuropsychologia</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>1767</fpage>
          <lpage>1776</lpage>
          <pub-id pub-id-type="pmid">17303196</pub-id>
        </citation>
      </ref>
      <ref id="bib109">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Starkstein</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bylsma</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Peyser</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Folstein</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Folstein</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study</article-title>
          <source>Neuroradiology</source>
          <year>1992</year>
          <volume>34</volume>
          <fpage>487</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="pmid">1436456</pub-id>
        </citation>
      </ref>
      <ref id="bib110">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stonnington</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Klöppel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Draganski</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Jack</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ashburner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Frackowiak</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>39</volume>
          <fpage>1180</fpage>
          <lpage>1185</lpage>
          <pub-id pub-id-type="pmid">18032068</pub-id>
        </citation>
      </ref>
      <ref id="bib111">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thieben</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Duggins</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mahant</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>McCusker</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Frackowiak</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>The distribution of structural neuropathology in pre-clinical Huntington's disease</article-title>
          <source>Brain</source>
          <year>2002</year>
          <volume>125</volume>
          <fpage>1815</fpage>
          <lpage>1828</lpage>
          <pub-id pub-id-type="pmid">12135972</pub-id>
        </citation>
      </ref>
      <ref id="bib112">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thiruvady</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Georgiou-Karistianis</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>G.F.</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sritharan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Farrow</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Churchyard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chua</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bradshaw</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Brawn</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Cunnington</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Functional connectivity of the prefrontal cortex in Huntington's disease</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2007</year>
          <volume>78</volume>
          <fpage>127</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">17028117</pub-id>
        </citation>
      </ref>
      <ref id="bib113">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Raamsdonk</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Slow</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Hossain</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Leavitt</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease</article-title>
          <source>J Neurosci</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>4169</fpage>
          <lpage>4180</lpage>
          <pub-id pub-id-type="pmid">15843620</pub-id>
        </citation>
      </ref>
      <ref id="bib114">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Raamsdonk</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Warby</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Hayden</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Selective degeneration in YAC mouse models of Huntington disease</article-title>
          <source>Brain Res Bull</source>
          <year>2007</year>
          <volume>72</volume>
          <fpage>124</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">17352936</pub-id>
        </citation>
      </ref>
      <ref id="bib115">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vemuri</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Whitwell</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Kantarci</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Josephs</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Parisi</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Shiung</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Knopman</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Boeve</surname>
              <given-names>B.F.</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Dickson</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Jack</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>Antemortem MRI based structural abnormality index (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage</article-title>
          <source>Neuroimage</source>
          <year>2008</year>
          <volume>42</volume>
          <fpage>559</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="pmid">18572417</pub-id>
        </citation>
      </ref>
      <ref id="bib116">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vonsattel</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>DiFiglia</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Huntington disease</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>1998</year>
          <volume>57</volume>
          <fpage>369</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="pmid">9596408</pub-id>
        </citation>
      </ref>
      <ref id="bib117">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wakana</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Caprihan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Panzenboeck</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Fallon</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gollub</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Hua</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Dubey</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Blitz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>van Zijl</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Reproducibility of quantitative tractography methods applied to cerebral white matter</article-title>
          <source>Neuroimage</source>
          <year>2007</year>
          <volume>36</volume>
          <fpage>630</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="pmid">17481925</pub-id>
        </citation>
      </ref>
      <ref id="bib118">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>F.O.</given-names>
            </name>
          </person-group>
          <article-title>Huntington's disease</article-title>
          <source>Lancet</source>
          <year>2007</year>
          <volume>369</volume>
          <fpage>218</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">17240289</pub-id>
        </citation>
      </ref>
      <ref id="bib119">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>V.C.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Gutekunst</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Vrbanac</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Vonsattel</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Gusella</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Hersch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Auerbach</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Joyner</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice</article-title>
          <source>Hum Mol Genet</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>503</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="pmid">10699173</pub-id>
        </citation>
      </ref>
      <ref id="bib120">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitwell</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Schott</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>MacManus</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>N.C.</given-names>
            </name>
          </person-group>
          <article-title>Using nine degrees-of-freedom registration to correct for changes in voxel size in serial MRI studies</article-title>
          <source>Magn Reson Imaging</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>993</fpage>
          <lpage>999</lpage>
          <pub-id pub-id-type="pmid">15288140</pub-id>
        </citation>
      </ref>
      <ref id="bib121">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Sambataro</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vasic</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schonfeldt-Lecuona</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease</article-title>
          <source>Exp Neurol</source>
          <year>2008</year>
          <volume>213</volume>
          <fpage>137</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">18588876</pub-id>
        </citation>
      </ref>
      <ref id="bib122">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Sambataro</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vasic</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schonfeldt-Lecuona</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load</article-title>
          <source>Eur J Neurol</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>1180</fpage>
          <lpage>1190</lpage>
          <pub-id pub-id-type="pmid">18754766</pub-id>
        </citation>
      </ref>
      <ref id="bib123">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Vasic</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schonfeldt-Lecuona</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>G.B.</given-names>
            </name>
          </person-group>
          <article-title>Cortical dysfunction in patients with Huntington's disease during working memory performance</article-title>
          <source>Hum Brain Mapp</source>
          <year>2008</year>
          <volume>30</volume>
          <fpage>327</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">18172852</pub-id>
        </citation>
      </ref>
      <ref id="bib124">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Vasic</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schonfeldt-Lecuona</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <fpage>2845</fpage>
          <lpage>2857</lpage>
          <pub-id pub-id-type="pmid">17855375</pub-id>
        </citation>
      </ref>
      <ref id="bib125">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of a novel event-related parametric fMRI paradigm investigating prefrontal function</article-title>
          <source>Psychiatry Res</source>
          <year>2005</year>
          <volume>140</volume>
          <fpage>73</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">16139997</pub-id>
        </citation>
      </ref>
      <ref id="bib126">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Banta</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Piotrowska-Nitsche</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Larkin</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Orkin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>Z.H.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bachevalier</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zola</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.J.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>A.W.</given-names>
            </name>
          </person-group>
          <article-title>Towards a transgenic model of Huntington's disease in a non-human primate</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>453</volume>
          <fpage>921</fpage>
          <lpage>924</lpage>
          <pub-id pub-id-type="pmid">18488016</pub-id>
        </citation>
      </ref>
      <ref id="bib127">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimbelman</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Mikos</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>fMRI detection of early neural dysfunction in preclinical Huntington's disease</article-title>
          <source>J Int Neuropsychol Soc</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>758</fpage>
          <lpage>769</lpage>
          <pub-id pub-id-type="pmid">17697407</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>The figure illustrates the impact of different smoothing kernels (ranging from 10 to 30 mm) on the apparent distribution and severity of cortical thinning.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Example displays areas with decreased GM (<italic>P</italic>&lt;0.001) as detected by VBM comparing early HD subjects to controls (see <xref rid="bib49" ref-type="bibr">Kassubek et al., 2005</xref>; for details on group characteristics and methodology).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Positive TCN identified by means of ICA in healthy controls (green) and pre-HD subjects (blue) during the delay period of a verbal working memory task (<xref rid="bib125 bib121" ref-type="bibr">Wolf and Walter, 2005; Wolf et al., 2008a</xref>). Top right: Within a predominantly frontostriatal TCN, areas with decreased connectivity in pre-HD individuals versus healthy comparison subjects comprised the left ventro- and dorsolateral prefrontal cortex, the left parietal lobule, the left insula, the bilateral putamen and the right caudate. Bottom right: Within a predominantly frontoparietal TCN, areas with decreased connectivity in pre-HD individuals versus healthy comparison subjects comprised the left dorsolateral prefrontal cortex and the left superior parietal cortex (<xref rid="bib122" ref-type="bibr">Wolf et al., 2008b</xref>). The 2nd level spatial maps are rendered on the anatomical templates implemented in MRIcron [<ext-link xlink:href="http://www.sph.sc.edu/comd/rorden/mricron/" ext-link-type="uri">http://www.sph.sc.edu/comd/rorden/mricron/</ext-link>] (left) and SPM5 (right).</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
  </floats-wrap>
</article>